Owens & Minor ( (OMI) ) has released its Q3 earnings. Here is a breakdown of the information Owens & Minor presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Owens & Minor, Inc. is a Fortune 500 global healthcare solutions company that provides essential products and services supporting care from hospitals to homes, with a focus on the home-based care sector. In its third quarter 2025 financial report, Owens & Minor announced a definitive agreement to sell its Products & Healthcare Services segment, positioning itself as a pure-play home-based care business. The company reported a slight increase in revenue to $697.3 million compared to $686.8 million in the same quarter last year. However, it recorded a net loss from continuing operations of $5.6 million, a decline from a net income of $1.3 million in the previous year. Adjusted net income from continuing operations was $19.9 million, down from $28.2 million in the prior year, while adjusted EBITDA was $92.2 million, a decrease from $107.7 million. Looking forward, Owens & Minor reaffirmed its financial guidance for 2025, projecting revenue between $2.76 billion and $2.82 billion, with adjusted EPS ranging from $1.02 to $1.07 and adjusted EBITDA between $376 million and $382 million. The company remains focused on its Patient Direct platform, aiming for sustainable growth and long-term value creation in the home-based care market.